Perreira Melissa, Kim Eun Ju, Thomas Craig J, Hanover John A
Chemical Biology Core Facility, National Institute of Diabetes and Digestive and Kidney Disorders, National Institutes of Health, Bethesda, MD 20892, USA.
Bioorg Med Chem. 2006 Feb 1;14(3):837-46. doi: 10.1016/j.bmc.2005.09.013. Epub 2005 Oct 7.
The potent O-GlcNAcase inhibitor PUGNAc was synthesized and two isomers based on the E and Z stereochemistry of the oxime moiety were separated, defined, and tested for activity. Several lines of evidence were examined in an effort to define the correct stereochemical assignments of each form of PUGNAc. The ability of the Z stereoisomer to undergo the Beckmann rearrangement was ultimately the most definitive proof. It was determined via both in vitro and intact cell experiments that the Z form of PUGNAc was vastly more potent an inhibitor of O-GlcNAcase than the E form.
合成了强效的O-连接的N-乙酰葡糖胺酶(O-GlcNAcase)抑制剂PUGNAc,并分离、鉴定了基于肟部分E和Z立体化学的两种异构体,并对其活性进行了测试。为了确定PUGNAc每种形式的正确立体化学归属,研究了几条证据线索。Z立体异构体进行贝克曼重排的能力最终成为了最确凿的证据。通过体外和完整细胞实验均确定,PUGNAc的Z形式作为O-GlcNAcase抑制剂的效力远高于E形式。